These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 31524955

  • 1. Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
    Argirion I, Zarins KR, Ruterbusch JJ, Vatanasapt P, Sriplung H, Seymour EK, Rozek LS.
    Cancer; 2020 Jan 01; 126(1):121-130. PubMed ID: 31524955
    [Abstract] [Full Text] [Related]

  • 2. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I, Zarins KR, Suwanrungruang K, Pongnikorn D, Chitapanarux I, Sriplung H, Vatanasapt P, Rozek LS.
    Asian Pac J Cancer Prev; 2020 Nov 01; 21(11):3291-3299. PubMed ID: 33247687
    [Abstract] [Full Text] [Related]

  • 3. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
    Hsu WL, Chien YC, Huang YT, Yu KJ, Ko JY, Lin CY, Tsou YA, Leu YS, Liao LJ, Chang YL, Su JY, Liu Z, Wang CP, Terng SD, Hua CH, Lee JC, Yang TL, Kate Hsiao CH, Wu MS, Tsai MH, Liu MJ, Lou PJ, Hildesheim A, Chen CJ, GEV-NPC Study Group.
    Cancer Med; 2020 Mar 01; 9(5):1867-1876. PubMed ID: 31925935
    [Abstract] [Full Text] [Related]

  • 4. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ, Zhou GQ, Wang YQ, Wang SY, Zhang WJ, Jin YN, Zhang F, Li L, Liu LZ, Cheng ZB, Ma J, Qi ZY, Sun Y.
    Chin J Cancer; 2017 Dec 29; 36(1):98. PubMed ID: 29284539
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
    Rumayor Piña A, Dos Santos HT, Carlos R, Altemani A, de Almeida OP.
    Int J Surg Pathol; 2017 Jun 29; 25(4):304-309. PubMed ID: 27881609
    [Abstract] [Full Text] [Related]

  • 6. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    Chen WJ, Xu WN, Wang HY, Chen XX, Li XQ, Xie SH, Lin DF, Cao SM.
    BMC Cancer; 2021 Jun 01; 21(1):651. PubMed ID: 34074258
    [Abstract] [Full Text] [Related]

  • 7. Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein-Barr Virus: An analysis of a prospective study in southern China.
    Hu T, Lin CY, Xie SH, Chen GH, Lu YQ, Ling W, Huang QH, Liu Q, Cao SM.
    Cancer Med; 2019 May 01; 8(5):2561-2571. PubMed ID: 30843658
    [Abstract] [Full Text] [Related]

  • 8. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR.
    Laryngoscope; 2020 Mar 01; 130(3):E83-E88. PubMed ID: 31188486
    [Abstract] [Full Text] [Related]

  • 9. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R, Tang LL, Mao YP, Du XJ, Chen L, Zhang ZC, Liu LZ, Tian L, Luo XT, Xie YB, Ren J, Sun Y, Ma J.
    Cancer; 2019 Jan 01; 125(1):79-89. PubMed ID: 30351466
    [Abstract] [Full Text] [Related]

  • 10. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH, Trung NQ, Dong LT, Trung LQ, Espinoza JL.
    J Cancer Res Clin Oncol; 2021 Mar 01; 147(3):713-723. PubMed ID: 33392659
    [Abstract] [Full Text] [Related]

  • 11. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
    Ji MF, Sheng W, Cheng WM, Ng MH, Wu BH, Yu X, Wei KR, Li FG, Lian SF, Wang PP, Quan W, Deng L, Li XH, Liu XD, Xie YL, Huang SJ, Ge SX, Huang SL, Liang XJ, He SM, Huang HW, Xia SL, Ng PS, Chen HL, Xie SH, Liu Q, Hong MH, Ma J, Yuan Y, Xia NS, Zhang J, Cao SM.
    Ann Oncol; 2019 Oct 01; 30(10):1630-1637. PubMed ID: 31373615
    [Abstract] [Full Text] [Related]

  • 12. Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein-Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China: a cohort study.
    Du JL, Chen SH, Huang QH, Xie SH, Ye YF, Gao R, Guo J, Yang MJ, Liu Q, Hong MH, Cao SM.
    Chin J Cancer; 2016 Aug 15; 35(1):78. PubMed ID: 27527073
    [Abstract] [Full Text] [Related]

  • 13. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
    Zhang JB, Huang SY, Wang TM, Dong SQ, He YQ, Zheng XH, Li XZ, Wang F, Jianbing M, Jia WH.
    EBioMedicine; 2018 Nov 15; 37():101-109. PubMed ID: 30420297
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
    Senyuta NB, Smirnova KV, Kondratova VN, Ignatova AV, Mudunov AM, Dushenkina TE, Liechtenstein AV, Gurtsevich VE.
    Vopr Virusol; 2019 Nov 15; 64(5):229-237. PubMed ID: 32167688
    [Abstract] [Full Text] [Related]

  • 15. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
    Liu SL, Sun XS, Li XY, Tang LQ, Chen QY, Lin HX, Liang YJ, Yan JJ, Lin C, Guo SS, Liu LT, Li Y, Xie HJ, Tang QN, Liang H, Guo L, Mai HQ.
    Cancer Commun (Lond); 2019 Mar 29; 39(1):14. PubMed ID: 30925939
    [Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma.
    Cavalieri S, Licitra L.
    Cancer; 2020 Aug 15; 126(16):3624-3626. PubMed ID: 32497251
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
    Ke K, Wang H, Fu S, Zhang Z, Duan L, Liu D, Ye J.
    Chin Med J (Engl); 2014 Aug 15; 127(2):294-9. PubMed ID: 24438619
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhang WR, Du YY, Guo CY, Zhou HX, Lin JY, Meng XH, Mo HY, Luo DH.
    Cancer Res Treat; 2021 Oct 15; 53(4):991-1003. PubMed ID: 33494127
    [Abstract] [Full Text] [Related]

  • 19. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM, Wided BA, Amine OE, Gritli S, ElMay M.
    Ann Otol Rhinol Laryngol; 2020 Oct 15; 129(10):1011-1019. PubMed ID: 32468823
    [Abstract] [Full Text] [Related]

  • 20. Nasopharyngeal Epstein-Barr virus DNA loads in high-risk nasopharyngeal carcinoma families: Familial aggregation and host heritability.
    Zheng MQ, Wang TM, Liao Y, Xue WQ, He YQ, Wu ZY, Yang DW, Li DH, Deng CM, Jia YJ, Yuan LL, Zhang WL, Luo LT, Tong XT, Wu YX, Zhou T, Li XZ, Tang LL, Zhang JB, Xia YF, Mu J, Jia WH.
    J Med Virol; 2020 Dec 15; 92(12):3717-3725. PubMed ID: 32558959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.